Find Alcaftadine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

6RELATED EXCIPIENT COMPANIES

6EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

GLOBAL SALES INFORMATION

Annual Reports

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 147084-10-4, Lastacaft, R89674, R-89674, R 89674, 7z8o94ecsx
Molecular Formula
C19H21N3O
Molecular Weight
307.4  g/mol
InChI Key
MWTBKTRZPHJQLH-UHFFFAOYSA-N
FDA UNII
7Z8O94ECSX

Alcaftadine
Alcaftadine is a H1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis. This drug was approved in July 2010.
Alcaftadine is a Histamine-1 Receptor Antagonist. The mechanism of action of alcaftadine is as a Histamine H1 Receptor Antagonist.
1 2D Structure

Alcaftadine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
11-(1-methylpiperidin-4-ylidene)-5,6-dihydroimidazo[2,1-b][3]benzazepine-3-carbaldehyde
2.1.2 InChI
InChI=1S/C19H21N3O/c1-21-9-6-15(7-10-21)18-17-5-3-2-4-14(17)8-11-22-16(13-23)12-20-19(18)22/h2-5,12-13H,6-11H2,1H3
2.1.3 InChI Key
MWTBKTRZPHJQLH-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CN1CCC(=C2C3=CC=CC=C3CCN4C2=NC=C4C=O)CC1
2.2 Other Identifiers
2.2.1 UNII
7Z8O94ECSX
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 147084-10-4

2. Lastacaft

3. R89674

4. R-89674

5. R 89674

6. 7z8o94ecsx

7. Chebi:71023

8. 11-(1-methylpiperidin-4-ylidene)-5,6-dihydroimidazo[2,1-b][3]benzazepine-3-carbaldehyde

9. Lastacaft (tn)

10. 11-(1-methylpiperidin-4-ylidene)-6,11-dihydro-5h-imidazo[2,1-b][3]benzazepine-3-carbaldehyde

11. 2-(1-methylpiperidin-4-ylidene)-4,7-diazatricyclo[8.4.0.0(3,7)]tetradeca- 1(14),3,5,10,12-pentaene-6-carbaldehyde

12. Alcaftadine [usan:inn]

13. Unii-7z8o94ecsx

14. Alcaftadina

15. Alcaftadinum

16. 5h-imidazo(2,1-b)(3)benzazepine-3-carboxaldehyde, 6,11-dihydro-11-(1-methyl-4-piperidinylidene)-

17. 5h-imidazo[2,1-b][3]benzazepine-3-carboxaldehyde, 6,11-dihydro-11-(1-methyl-4-piperidinylidene)-

18. Alcaftadine [inn]

19. Alcaftadine [jan]

20. Alcaftadine [usan]

21. Alcaftadine [vandf]

22. Alcaftadine [mart.]

23. Alcaftadine [who-dd]

24. Alcaftadine (jan/usan/inn)

25. Gtpl7587

26. Schembl1602418

27. Chembl1201747

28. Alcaftadine, >=98% (hplc)

29. (unlabelled)alcaftadine-13c-d3

30. Alcaftadine [orange Book]

31. Dtxsid80598455

32. Hms3885b12

33. Bcp04261

34. Mfcd09954106

35. S4625

36. Zinc11726211

37. Akos025402002

38. Am84429

39. Bcp9000269

40. Ccg-267551

41. Db06766

42. Ncgc00390732-04

43. 5h-imidazo[2,1-b][3]benzazepine-3-carboxaldehyde,6,11-dihydro-11-(1-methyl-4-piperidinylidene)-

44. Ac-28019

45. As-56303

46. Hy-17039

47. Bcp0726000082

48. Db-063693

49. Ft-0661472

50. A16393

51. D06552

52. Q4712900

53. 11-(1-methylpiperidin-4-ylidene)-5,6-dihydroimidazo[2,3-b][3]benzazepine-3-carbaldehyde

54. 11-(1-methylpiperidin-4-ylidene)-6,11-dihydro-5h-benzo[d]imidazo[1,2-a]azepine-3-carbaldehyde

55. 11-(1-methylpiperidin-4-ylidene)-6,11-dihydro-5h-imidazolo(2,1-b)(3)benzazepine-3-carbaldehyde

56. 2-(1-methylpiperidin-4-ylidene)-4,7-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(14),3,5,10,12-pentaene-6-carbaldehyde

57. 4-(1-methyl-piperidin-4-ylidene)-9,10-dihydro-4h-3,10a-diaza-benzo(f)azulene-1-carbaldehyde

58. 5h-imidazo(2,1-b)(3)benzazepine-3-carboxaldehyde, 6,11-dihydro-11-(1-methyl-4- Piperidinylidene)-

2.4 Create Date
2007-12-04
3 Chemical and Physical Properties
Molecular Weight 307.4 g/mol
Molecular Formula C19H21N3O
XLogP31.7
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count3
Rotatable Bond Count1
Exact Mass307.168462302 g/mol
Monoisotopic Mass307.168462302 g/mol
Topological Polar Surface Area38.1 Ų
Heavy Atom Count23
Formal Charge0
Complexity479
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameLastacaft
PubMed HealthAlcaftadine (Into the eye)
Drug ClassesOphthalmologic Agent
Drug LabelLASTACAFT is a sterile, topically administered H1 receptor antagonist containing alcaftadine for ophthalmic use. Alcaftadine is a white to yellow powder with an empirical formula of C19H21N3O and a molecular weight of 307.39. Contains: Active: alca...
Active IngredientAlcaftadine
Dosage FormSolution/drops
RouteOphthalmic
Strength0.25%
Market StatusPrescription
CompanyAllergan

2 of 2  
Drug NameLastacaft
PubMed HealthAlcaftadine (Into the eye)
Drug ClassesOphthalmologic Agent
Drug LabelLASTACAFT is a sterile, topically administered H1 receptor antagonist containing alcaftadine for ophthalmic use. Alcaftadine is a white to yellow powder with an empirical formula of C19H21N3O and a molecular weight of 307.39. Contains: Active: alca...
Active IngredientAlcaftadine
Dosage FormSolution/drops
RouteOphthalmic
Strength0.25%
Market StatusPrescription
CompanyAllergan

4.2 Drug Indication

For the prevention of itching associated with allergic conjunctivitis.


FDA Label


5 Pharmacology and Biochemistry
5.1 Pharmacology

Following bilateral topical ocular administration of alcaftadine ophthalmic solution, 0.25%, the mean plasma Cmax of alcaftadine was approximately 60 pg/mL and the median Tmax occurred at 15 minutes. Plasma concentrations of alcaftadine were below the lower limit of quantification (10 pg/mL) by 3 hours after dosing. The mean Cmax of the active carboxylic acid metabolite was approximately 3 ng/mL and occurred at 1 hour after dosing. Plasma concentrations of the carboxylic acid metabolite were below the lower limit of quantification (100 pg/mL) by 12 hours after dosing.


5.2 MeSH Pharmacological Classification

Histamine H1 Antagonists

Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)


5.3 FDA Pharmacological Classification
5.3.1 Active Moiety
ALCAFTADINE
5.3.2 FDA UNII
7Z8O94ECSX
5.3.3 Pharmacological Classes
Histamine-1 Receptor Antagonist [EPC]; Histamine H1 Receptor Antagonists [MoA]
5.4 ATC Code

S - Sensory organs

S01 - Ophthalmologicals

S01G - Decongestants and antiallergics

S01GX - Other antiallergics

S01GX11 - Alcaftadine


5.5 Absorption, Distribution and Excretion

Route of Elimination

Based on data following oral administration of alcaftadine, the carboxylic acid metabolite is primarily eliminated unchanged in the urine.


5.6 Metabolism/Metabolites

The metabolism of alcaftadine is mediated by non-CYP450 cytosolic enzymes to the active carboxylic acid metabolite.


5.7 Biological Half-Life

The elimination half-life of the carboxylic acid metabolite is approximately 2 hours following topical ocular administration.


5.8 Mechanism of Action

Alcaftadine is a H1 histamine receptor antagonist and inhibitor of the release of histamine from mast cells. Decreased chemotaxis and inhibition of eosinophil activation has also been demonstrated.


USDMF

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNeuland Laboratories- A dedicated 100% API provider.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2015-01-05

Pay. Date : 2014-11-24

DMF Number : 28277

Submission : 2014-05-08

Status : Active

Type : II

Neuland

02

RDD 2025
Not Confirmed

03

Cilag Ag

Switzerland

USDMF

arrow
RDD 2025
Not Confirmed

03

Cilag Ag

Switzerland
arrow
RDD 2025
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 20066

Submission : 2006-12-21

Status : Active

Type : II

blank

04

Curia Spain Sau

U.S.A

USDMF

arrow
RDD 2025
Not Confirmed

04

RDD 2025
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2014-04-11

Pay. Date : 2014-02-24

DMF Number : 27982

Submission : 2014-02-18

Status : Active

Type : II

blank

05

RDD 2025
Not Confirmed

05

RDD 2025
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 27559

Submission : 2013-12-21

Status : Inactive

Type : II

blank

06

RDD 2025
Not Confirmed
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-moreread-more

01

RDD 2025
Not Confirmed
arrow
arrow
RDD 2025
Not Confirmed

Alcaftadine IH

Date of Issue : 2022-06-17

Valid Till : 2025-07-14

Written Confirmation Number : WC-0021n

Address of the Firm : Sy. Nos: 317, 320, 321, 322, 323, 604 & 605, Rudraram (Village), Patancheru (Man...

blank

02

RDD 2025
Not Confirmed
arrow
arrow
RDD 2025
Not Confirmed

Alcaftadine IH

Date of Issue : 2022-01-04

Valid Till : 2022-07-14

Written Confirmation Number : WC-0021A4

Address of the Firm : Sy. No.317&323, Rudraram Village, Patancheru Mandal, Sangaredy District-502329 T...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

read-more
read-moreread-more

01

Cilag AG

Switzerland
RDD 2025
Not Confirmed
arrow

Cilag AG

Switzerland
arrow
RDD 2025
Not Confirmed

Alkaftaddin

Registrant Name : AbbVie Korea Inc.

Registration Date : 2012-04-20

Registration Number : 5242-3-ND

Manufacturer Name : Cilag AG

Manufacturer Address : Hochstrasse 201, 8200 Schaffhausen

blank

02

Curia

U.S.A
RDD 2025
Not Confirmed
arrow

Curia

U.S.A
arrow
RDD 2025
Not Confirmed

Alcaftadine

Registrant Name : Samoh Pharmaceutical Co., Ltd.

Registration Date : 2018-11-09

Registration Number : 207-38-ND

Manufacturer Name : CURIA SPAIN SAU

Manufacturer Address : Parque Tecnológico Boecillo, Parcelas 2y 3, Boecillo, 47151 Valladolid, Spain

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

RDD 2025
Not Confirmed
arrow
arrow
RDD 2025
Not Confirmed

ALCAFTADINE

NDC Package Code : 42973-204

Start Marketing Date : 2017-12-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

02

Cilag AG

Switzerland
RDD 2025
Not Confirmed
arrow

Cilag AG

Switzerland
arrow
RDD 2025
Not Confirmed

ALCAFTADINE

NDC Package Code : 12502-5263

Start Marketing Date : 2010-01-14

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

03

RDD 2025
Not Confirmed
arrow
arrow
RDD 2025
Not Confirmed

ALCAFTADINE

NDC Package Code : 65089-0063

Start Marketing Date : 2023-03-10

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

04

RDD 2025
Not Confirmed
arrow
arrow
RDD 2025
Not Confirmed

ALCAFTADINE

NDC Package Code : 14501-0020

Start Marketing Date : 2015-02-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content

Alcaftadine

About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...

HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It offers services such as sourcing, manufacturing & supply, helping partners enter new markets worldwide. Its strong partnerships with major players in the pharma and food additive industries help HRV Global effectively promote projects and products. HRV Global represents over 30 large Indian drugmakers, primarily targeting Europe, the US & the Middle East markets. Headquartered in India, HRV Global has offices in the US, Switzerland, Dubai, Lithuania & Turkey.
HRV Global Life Sciences

02

Apicore

India
RDD 2025
Not Confirmed
arrow

Apicore

India
arrow
RDD 2025
Not Confirmed

Alcaftadine

About the Company : Apicore LLC, a wholly owned subsidiary of RK Pharma Inc is a leading process R&D and API manufacturing service provider for the worldwide pharmaceutical industry. We offer a wide p...

Apicore LLC, a wholly owned subsidiary of RK Pharma Inc is a leading process R&D and API manufacturing service provider for the worldwide pharmaceutical industry. We offer a wide portfolio of services ranging from API’s for the generic industry to custom synthesis for early phase pharmaceutical research and branded products. Our USFDA approved facilities in India (Visakhapatnam, Andhra Pradesh and Vadodara, Gujarat) are both equipped with state-of-the-art analytical and research capabilities. While our worldwide network of locations seamlessly integrate with each other, each unit also independently houses a full
blank

03

Curia

U.S.A
RDD 2025
Not Confirmed
arrow

Curia

U.S.A
arrow
RDD 2025
Not Confirmed

Alcaftadine

About the Company : Curia is a global contract research, development and manufacturing organization (CDMO), offering products and services across the drug development spectrum to help our partners tur...

Curia is a global contract research, development and manufacturing organization (CDMO), offering products and services across the drug development spectrum to help our partners turn their ideas into real-world impact. We partner closely with pharmaceutical and biotechnology companies to boost business performance and improve patients’ lives. From early discovery and development through manufacturing and commercialization, our suite of custom solutions allows us to tailor every engagement to your precise needs, whether that’s an independent project or an opportunity that cuts across the drug continuum.
blank

04

RDD 2025
Not Confirmed
arrow
arrow
RDD 2025
Not Confirmed

Alcaftadine

About the Company : Enaltec Labs was established in 2006 by a group of young & experienced professionals with the specific objective to develop & produce complex, small volume, technology driven produ...

Enaltec Labs was established in 2006 by a group of young & experienced professionals with the specific objective to develop & produce complex, small volume, technology driven products at competitive prices, thus providing the critical India advantage to generic formulators across the world. The paradigm shift of leading Indian pharmaceutical companies to target high volume and blockbuster products for regulated markets has been the inspiration behind the launch of Enaltec Labs.
blank

05

RDD 2025
Not Confirmed
arrow
arrow
RDD 2025
Not Confirmed

Alcaftadine

About the Company : Enaltec Labs was established in 2006 by a group of young & experienced professionals with the specific objective to develop & produce complex, small volume, technology driven produ...

Enaltec Labs was established in 2006 by a group of young & experienced professionals with the specific objective to develop & produce complex, small volume, technology driven products at competitive prices, thus providing the critical India advantage to generic formulators across the world. The paradigm shift of leading Indian pharmaceutical companies to target high volume and blockbuster products for regulated markets has been the inspiration behind the launch of Enaltec Labs.
blank

06

RDD 2025
Not Confirmed
arrow
arrow
RDD 2025
Not Confirmed

Alcaftadine

About the Company : Flax Laboratories was established by a group of young and experienced professionals with the specific objective to develop and produce complex, small volume, technology driven bulk...

Flax Laboratories was established by a group of young and experienced professionals with the specific objective to develop and produce complex, small volume, technology driven bulk drugs and intermediates at competitive price. Our objective of providing the critical India advantage to both the innovator and generic pharmaceutical players in both domestic and international markets including the regulated markets.
blank

07

RDD 2025
Not Confirmed
arrow
arrow
RDD 2025
Not Confirmed

Alcaftadine

About the Company : Globofarm International Pvt Ltd is a well-informed, highly efficient, Swiftly functioning competitive sourcing entity. We serve private, institutional, and corporate clients worldw...

Globofarm International Pvt Ltd is a well-informed, highly efficient, Swiftly functioning competitive sourcing entity. We serve private, institutional, and corporate clients worldwide in the field of Pharmaceuticals & Nutraceuticals. We combine our contacts, expertise, and core competency with our operations to deliver superior pharmaceutical sourcing solutions to our customers. Having our base in India, Globofarm International Pvt Ltd has been serving clients globally.
blank

08

RDD 2025
Not Confirmed
arrow
arrow
RDD 2025
Not Confirmed

Alcaftadine

About the Company : Globofarm International Pvt Ltd is a well-informed, highly efficient, Swiftly functioning competitive sourcing entity. We serve private, institutional, and corporate clients worldw...

Globofarm International Pvt Ltd is a well-informed, highly efficient, Swiftly functioning competitive sourcing entity. We serve private, institutional, and corporate clients worldwide in the field of Pharmaceuticals & Nutraceuticals. We combine our contacts, expertise, and core competency with our operations to deliver superior pharmaceutical sourcing solutions to our customers. Having our base in India, Globofarm International Pvt Ltd has been serving clients globally.
blank

09

RDD 2025
Not Confirmed
arrow
arrow
RDD 2025
Not Confirmed

Alcaftadine

About the Company : Micro Labs Limited is a diversified healthcare company with cutting-edge R&D, advanced manufacturing facilities, and a strong distribution network. It ranks among India's top pharm...

Micro Labs Limited is a diversified healthcare company with cutting-edge R&D, advanced manufacturing facilities, and a strong distribution network. It ranks among India's top pharmaceutical companies, with a leading presence in cardiology, diabetology, anti-infectives, ophthalmology, and pain management. The company is known for its high-quality medicines, including the popular fever management brand, Dolo. Micro Labs continues to grow through innovation, research, and global expansion, delivering healthcare solutions that meet international standards.
blank

10

RDD 2025
Not Confirmed
arrow
arrow
RDD 2025
Not Confirmed

Alcaftadine

About the Company : Founded in 2003, Hyderabad-based MSN Labs is one of the fastest-growing research-based pharmaceutical company in India. Boasting a diverse product portfolio, with multiple products...

Founded in 2003, Hyderabad-based MSN Labs is one of the fastest-growing research-based pharmaceutical company in India. Boasting a diverse product portfolio, with multiple products in the market and in the pipeline, MSN has 6 API (including Oncology) and one finished dosage facilities (one more for Oncology is being built) and an integrated R&D Center for Contract Research And Manufacturing Services (CRAMS) located in Hyderabad. MSN has won the trust of more than 250 customers across 65 countries around the globe covering the US, Europe, Latin America, Middle-East, Asia Pacific, Africa and CIS markets. Our product basket offers 100 APIs
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1652293800,"product":"ALCAFTADINE (TAX INVOICE NO:1900225102 D","address":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD","city":"HYDERABAD","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"BASLE","customer":"AIRPHARM","customerCountry":"SWITZERLAND","quantity":"0.25","actualQuantity":"0.25","unit":"KGS","unitRateFc":"89100","totalValueFC":"21530.5","currency":"USD","unitRateINR":6656000,"date":"12-May-2022","totalValueINR":"1664000","totalValueInUsd":"21530.5","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"1333669","productDescription":"API","marketType":"REGULATED MARKET","country":"SWITZERLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1668018600,"product":"ALCAFTADINE","address":"1701,17TH FL KESAR SOLITAIRE PLOT NO5, SECTOR 19 ,SANPADA,","city":"NAVI MUMBAI","supplier":"ENALTEC LABS PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"PRIME BANK LIMITED ","customerCountry":"BANGLADESH","quantity":"0.07","actualQuantity":"0.065","unit":"KGS","unitRateFc":"95000","totalValueFC":"6212.3","currency":"USD","unitRateINR":7800000,"date":"10-Nov-2022","totalValueINR":"507000","totalValueInUsd":"6212.3","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"5364957","productDescription":"API","marketType":"","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"1701,17TH FL KESAR SOLITAIRE PLOT NO5, SECTOR 19 ,SANPADA,, NAVI MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1675103400,"product":"PHARMACEUTICAL RAW MATERIAL- ALCAFTADINE","address":"B-29\/1, MIDC MAHAD,,BIRWADI VILLAG E ROAD","city":"MAHAD,MAHARASHTRA","supplier":"FLAX LABORATORIES","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"CREDIT AGRICOLE EGYPT","customerCountry":"EGYPT","quantity":"0.30","actualQuantity":"300","unit":"GMS","unitRateFc":"42","totalValueFC":"12377.8","currency":"USD","unitRateINR":3373.3333333333335,"date":"31-Jan-2023","totalValueINR":"1012000","totalValueInUsd":"12377.8","indian_port":"BOMBAY AIR","hs_no":"29333990","bill_no":"7420449","productDescription":"API","marketType":"","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"B-29\/1, MIDC MAHAD,,BIRWADI VILLAG E ROAD, MAHAD,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1676917800,"product":"ALCAFTADINE (PHARMACEUTICAL RAW MATERIAL","address":"1701,17TH FL KESAR SOLITAIRE PLOT NO5, SECTOR 19 ,SANPADA,","city":"NAVI MUMBAI","supplier":"ENALTEC LABS PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"TO ORDER","customerCountry":"EGYPT","quantity":"0.25","actualQuantity":"0.25","unit":"KGS","unitRateFc":"44000","totalValueFC":"10897.2","currency":"USD","unitRateINR":3600000,"date":"21-Feb-2023","totalValueINR":"900000","totalValueInUsd":"10897.2","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"7936151","productDescription":"API","marketType":"","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"1701,17TH FL KESAR SOLITAIRE PLOT NO5, SECTOR 19 ,SANPADA,, NAVI MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1683138600,"product":"PHARMACEUTICAL RAW MATERIAL ALCAFTADINEIH BATCH NO ALC 22 002 MFG DATE JUL 2022 RETEST DATE JUN 2025","address":"N\/A","city":"N\/A","supplier":"FLAX LABORATORIES","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"QNB BANK","customerCountry":"EGYPT","quantity":"0.25","actualQuantity":"250","unit":"GMS","unitRateFc":"40","totalValueFC":"9868.2","currency":"USD","unitRateINR":3248,"date":"04-May-2023","totalValueINR":"812000","totalValueInUsd":"9868.2","indian_port":"BOMBAY AIR","hs_no":"29242990","bill_no":"0","productDescription":"API","marketType":"","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"N\/A, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1683484200,"product":"PHARMACEUTICAL RAW MATERIAL ALCAFTADINEIH BATCH NO ALC 22 002 MFG DATE JUL 2022 RETEST DATE JUN 2025","address":"N\/A","city":"N\/A","supplier":"FLAX LABORATORIES","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"QNB BANK","customerCountry":"EGYPT","quantity":"0.25","actualQuantity":"250","unit":"GMS","unitRateFc":"40","totalValueFC":"9734.6","currency":"USD","unitRateINR":3204,"date":"08-May-2023","totalValueINR":"801000","totalValueInUsd":"9734.6","indian_port":"BOMBAY AIR","hs_no":"29242990","bill_no":"0","productDescription":"API","marketType":"","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"N\/A, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1687890600,"product":"PHARMACEUTICAL RAW MATERIAL -ALCAFTADINE","address":"","city":"","supplier":"FLAX LABORATORIES","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"COMMERCIAL INTERNATIONAL BANK","customerCountry":"EGYPT","quantity":"0.50","actualQuantity":"500","unit":"GMS","unitRateFc":"42","totalValueFC":"20670","currency":"USD","unitRateINR":3397.9998780000001,"date":"28-Jun-2023","totalValueINR":"1698999.939","totalValueInUsd":"20670","indian_port":"BOMBAY AIR","hs_no":"29242990","bill_no":"0","productDescription":"API","marketType":"","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1691519400,"product":"ALCAFTADINE","address":"NA","city":"MUMBAI","supplier":"ENALTEC LABS PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"DHAKA BANK LIMITED","customerCountry":"BANGLADESH","quantity":"0.25","actualQuantity":"0.25","unit":"KGS","unitRateFc":"82000","totalValueFC":"20156.1","currency":"USD","unitRateINR":6678617.4000000004,"date":"09-Aug-2023","totalValueINR":"1669654.35","totalValueInUsd":"20156.1","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"0","productDescription":"API","marketType":"","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"NA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1693506600,"product":"PHARMACEUTICAL RAW MATERIAL - ALCAFTADINE IH BATCH NO. - ALC\/23\/001 MFG. DATE -AUG, 2023 RETEST DATE - JULY, 2026","address":"PLOT NO.B-29\/1 MIDC","city":"MAHAD","supplier":"FLAX LABORATORIES","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"COMMERCIAL INTERNATIONAL BANK","customerCountry":"EGYPT","quantity":"0.50","actualQuantity":"500","unit":"GMS","unitRateFc":"42","totalValueFC":"20684.7","currency":"USD","unitRateINR":3434,"date":"01-Sep-2023","totalValueINR":"1717000","totalValueInUsd":"20684.7","indian_port":"Bombay Air","hs_no":"29242990","bill_no":"3649285","productDescription":"API","marketType":"","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT NO.B-29\/1 MIDC, MAHAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1696357800,"product":"PHARMACEUTICAL RAW MATERIAL- ALCAFTADINEIH (MICRONIZED & STERILE) B.NO. ALC\/23\/002 MFG.DT- SEP,2023 RETEST DT- AUG,2026","address":"PLOT NO.B-29\/1 MIDC","city":"MAHAD","supplier":"FLAX LABORATORIES","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"AHLI UNITED BANK","customerCountry":"EGYPT","quantity":"0.55","actualQuantity":"550","unit":"GMS","unitRateFc":"43","totalValueFC":"23261","currency":"USD","unitRateINR":3520,"date":"04-Oct-2023","totalValueINR":"1936000","totalValueInUsd":"23261","indian_port":"Bombay Air","hs_no":"29242990","bill_no":"4395846","productDescription":"API","marketType":"","country":"EGYPT","selfForZScoreResived":"Micronized","supplierPort":"Bombay Air","supplierAddress":"PLOT NO.B-29\/1 MIDC, MAHAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1696357800,"product":"PHARMACEUTICAL RAW MATERIAL- ALCAFTADINEIH. B.NO. ALC\/23\/002 MFG.DT- SEP,2023 RETEST DT- AUG,2026","address":"PLOT NO.B-29\/1 MIDC","city":"MAHAD","supplier":"FLAX LABORATORIES","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"QNB BANK, BEIRUT BRANCH","customerCountry":"EGYPT","quantity":"0.50","actualQuantity":"500","unit":"GMS","unitRateFc":"40","totalValueFC":"19668.6","currency":"USD","unitRateINR":3274,"date":"04-Oct-2023","totalValueINR":"1637000","totalValueInUsd":"19668.6","indian_port":"Bombay Air","hs_no":"29242990","bill_no":"4395847","productDescription":"API","marketType":"","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT NO.B-29\/1 MIDC, MAHAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1703010600,"product":"PHARMACEUTICAL RAW MATERIAL- ALCAFTADINEIH (B.NO.ALC\/23\/002 M.DT. SEP, 2023, RETEST DT- AUG, 2026","address":"PLOT NO.B-29\/1 MIDC","city":"MAHAD","supplier":"FLAX LABORATORIES","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"COMMERCIAL INTERNATIONAL BANK","customerCountry":"EGYPT","quantity":"0.42","actualQuantity":"420","unit":"GMS","unitRateFc":"41","totalValueFC":"16974.4","currency":"USD","unitRateINR":3364.2857142857142,"date":"20-Dec-2023","totalValueINR":"1413000","totalValueInUsd":"16974.4","indian_port":"Bombay Air","hs_no":"29242990","bill_no":"6174894","productDescription":"API","marketType":"","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT NO.B-29\/1 MIDC, MAHAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1704997800,"product":"PHARMACEUTICAL RAW MATERIAL- ALCAFTADINEIH (B.NO.ALC\/23\/002 M.DT. SEP, 2023, RETEST DT- AUG, 2026","address":"PLOT NO.B-29\/1 MIDC","city":"MAHAD","supplier":"FLAX LABORATORIES","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"QNB BANK","customerCountry":"EGYPT","quantity":"0.50","actualQuantity":"500","unit":"GMS","unitRateFc":"40","totalValueFC":"19740","currency":"USD","unitRateINR":3281.248,"date":"12-Jan-2024","totalValueINR":"1640624","totalValueInUsd":"19740","indian_port":"Bombay Air","hs_no":"29242990","bill_no":"6721591","productDescription":"API","marketType":"","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT NO.B-29\/1 MIDC, MAHAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1713810600,"product":"ALCAFTADINE","address":"1706,17TH FL KESAR SOLITAIRE PLOT","city":"NAVI MUMBAI, MAHARASHTRA","supplier":"ENALTEC LABS PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"","customer":"PRIME BANK PLC.TRADE SERVICE DIVISI","customerCountry":"BANGLADESH","quantity":"0.07","actualQuantity":"0.066","unit":"KGS","unitRateFc":"83150","totalValueFC":"5448","currency":"USD","unitRateINR":6893136.3636363633,"date":"23-Apr-2024","totalValueINR":"454947","totalValueInUsd":"5448","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"9324474","productDescription":"API","marketType":"","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"1706,17TH FL KESAR SOLITAIRE PLOT, NAVI MUMBAI, MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1726079400,"product":"PHARMACEUTICAL RAW MATERIAL-ALCAFTADINEIH BATCH NO.ALC\/24\/001 MFG.DT.-MAY, 2024RETEST DATE - APR, 2027","address":"PLOT NO.B-29\/1 MIDC","city":"MAHAD","supplier":"FLAX LABORATORIES","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"PHARCO PHARMACEUTICALS","customerCountry":"EGYPT","quantity":"0.02","actualQuantity":"15","unit":"GMS","unitRateFc":"48","totalValueFC":"642.8","currency":"USD","unitRateINR":3591.1999999999998,"date":"12-Sep-2024","totalValueINR":"53868","totalValueInUsd":"642.8","indian_port":"Bombay Air","hs_no":"29242990","bill_no":"3960616","productDescription":"API","marketType":"","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT NO.B-29\/1 MIDC, MAHAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1734460200,"product":"ALCAFTADINE IH (BATCH NO. ALC\/24\/003 MFG. DATE OCT, 2024 RETEST DATE SEP, 2027)","address":"PLOT NO.B-29\/1 MIDC","city":"MAHAD","supplier":"FLAX LABORATORIES","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"QNB BANK","customerCountry":"EGYPT","quantity":"0.75","actualQuantity":"750","unit":"GMS","unitRateFc":"39.9","totalValueFC":"29544.3","currency":"USD","unitRateINR":3347.1373333333331,"date":"18-Dec-2024","totalValueINR":"2510353","totalValueInUsd":"29544.3","indian_port":"Bombay Air","hs_no":"29242990","bill_no":"6555231","productDescription":"API","marketType":"","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT NO.B-29\/1 MIDC, MAHAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1740594600,"product":"ALCAFTADINE IH BATCH NO:- ALC\/24\/003","address":"PLOT NO.B-29\/1 MIDC","city":"MAHAD","supplier":"FLAX LABORATORIES","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"EXPORT DEVELOPMENT BANK ","customerCountry":"EGYPT","quantity":"0.25","actualQuantity":"0.25","unit":"KGS","unitRateFc":"43000","totalValueFC":"10562.8","currency":"N\/A","unitRateINR":3674335,"date":"27-Feb-2025","totalValueINR":"918583.75","totalValueInUsd":"10562.8","indian_port":"Bombay Air","hs_no":"29333990","bill_no":"8568096","productDescription":"API","marketType":"","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT NO.B-29\/1 MIDC, MAHAD","customerAddress":""}]
12-May-2022
27-Feb-2025
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

FDF Dossiers

read-more
read-more

01

AbbVie Inc

U.S.A

ALCAFTADINE

Brand Name : LASTACAFT

Dosage Form : SOLUTION/DROPS;OPHTHALMIC

Dosage Strength : 0.25%

Packaging :

Approval Date : 2010-07-28

Application Number : 22134

Regulatory Info : OTC

Registration Country : USA

Abbvie Company Banner

02

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

ALCAFTADINE

Brand Name : ALCAFTADINE

Dosage Form : SOLUTION/DROPS;OPHTHALMIC

Dosage Strength : 0.25%

Packaging :

Approval Date : 2024-10-02

Application Number : 209290

Regulatory Info : OTC

Registration Country : USA

blank

03

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

ALCAFTADINE

Brand Name : ALCAFTADINE

Dosage Form : SOLUTION/DROPS;OPHTHALMIC

Dosage Strength : 0.25%

Packaging :

Approval Date : 2023-06-23

Application Number : 210659

Regulatory Info : DISCN

Registration Country : USA

blank

04

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

ALCAFTADINE

Brand Name : ALCAFTADINE

Dosage Form : SOLUTION/DROPS;OPHTHALMIC

Dosage Strength : 0.25%

Packaging :

Approval Date : 2024-03-01

Application Number : 209706

Regulatory Info : OTC

Registration Country : USA

blank

05

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Alcaftadine

Brand Name :

Dosage Form : Ophthalmic Solution

Dosage Strength : 0.25%/W/V

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Parenteral

read-more
read-more

Solubilizers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Looking for 147084-10-4 / Alcaftadine API manufacturers, exporters & distributors?

Alcaftadine manufacturers, exporters & distributors 1

35

PharmaCompass offers a list of Alcaftadine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Alcaftadine manufacturer or Alcaftadine supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Alcaftadine manufacturer or Alcaftadine supplier.

PharmaCompass also assists you with knowing the Alcaftadine API Price utilized in the formulation of products. Alcaftadine API Price is not always fixed or binding as the Alcaftadine Price is obtained through a variety of data sources. The Alcaftadine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Alcaftadine

Synonyms

147084-10-4, Lastacaft, R89674, R-89674, R 89674, 7z8o94ecsx

Cas Number

147084-10-4

Unique Ingredient Identifier (UNII)

7Z8O94ECSX

About Alcaftadine

Alcaftadine is a H1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis. This drug was approved in July 2010.

Alcaftadine Manufacturers

A Alcaftadine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Alcaftadine, including repackagers and relabelers. The FDA regulates Alcaftadine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Alcaftadine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Alcaftadine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Alcaftadine Suppliers

A Alcaftadine supplier is an individual or a company that provides Alcaftadine active pharmaceutical ingredient (API) or Alcaftadine finished formulations upon request. The Alcaftadine suppliers may include Alcaftadine API manufacturers, exporters, distributors and traders.

click here to find a list of Alcaftadine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Alcaftadine USDMF

A Alcaftadine DMF (Drug Master File) is a document detailing the whole manufacturing process of Alcaftadine active pharmaceutical ingredient (API) in detail. Different forms of Alcaftadine DMFs exist exist since differing nations have different regulations, such as Alcaftadine USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Alcaftadine DMF submitted to regulatory agencies in the US is known as a USDMF. Alcaftadine USDMF includes data on Alcaftadine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Alcaftadine USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Alcaftadine suppliers with USDMF on PharmaCompass.

Alcaftadine KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Alcaftadine Drug Master File in Korea (Alcaftadine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Alcaftadine. The MFDS reviews the Alcaftadine KDMF as part of the drug registration process and uses the information provided in the Alcaftadine KDMF to evaluate the safety and efficacy of the drug.

After submitting a Alcaftadine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Alcaftadine API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Alcaftadine suppliers with KDMF on PharmaCompass.

Alcaftadine WC

A Alcaftadine written confirmation (Alcaftadine WC) is an official document issued by a regulatory agency to a Alcaftadine manufacturer, verifying that the manufacturing facility of a Alcaftadine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Alcaftadine APIs or Alcaftadine finished pharmaceutical products to another nation, regulatory agencies frequently require a Alcaftadine WC (written confirmation) as part of the regulatory process.

click here to find a list of Alcaftadine suppliers with Written Confirmation (WC) on PharmaCompass.

Alcaftadine NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Alcaftadine as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Alcaftadine API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Alcaftadine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Alcaftadine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Alcaftadine NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Alcaftadine suppliers with NDC on PharmaCompass.

Alcaftadine GMP

Alcaftadine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Alcaftadine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Alcaftadine GMP manufacturer or Alcaftadine GMP API supplier for your needs.

Alcaftadine CoA

A Alcaftadine CoA (Certificate of Analysis) is a formal document that attests to Alcaftadine's compliance with Alcaftadine specifications and serves as a tool for batch-level quality control.

Alcaftadine CoA mostly includes findings from lab analyses of a specific batch. For each Alcaftadine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Alcaftadine may be tested according to a variety of international standards, such as European Pharmacopoeia (Alcaftadine EP), Alcaftadine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Alcaftadine USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty